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Abstract:  Problem  statement:  The  function  of  a  protein  is  dependent  on  its  three-dimensional 
structure.  However,  numerous  proteins  lacking  intrinsic  globular  3D  structure  under  physiological 
conditions had been recognized. These proteins are frequently involved in some of the most critical 
cellular control mechanisms and it appears that their rapid turnover, aided by their unstructured nature 
in the unbound state, provides a level of control that allows rapid and accurate responses of the cell to 
changing  environmental  conditions.  Approach:  A  significant  number  of  proteins  known  to  be 
involved in protein deposition disorders were now considered to Be Intrinsically Unstructured Proteins 
(IUPs). For example, Aβ peptide and tau protein in Alzheimer’s disease, PrP in Prion’s disease and α-
Synuclein  in  Parkinson’s  disease.  The  disorder  of  intrinsically  unstructured  proteins  (IUP's)  was 
crucial to their functions. They may adopt defined but extended structures when bound to cognate 
ligands. Their amino acid compositions were less hydrophobic than those of soluble proteins. They 
lack hydrophobic cores and hence did not become insoluble when heated. About 40% of eukaryotic 
proteins had at least one long (>50 residues) disordered region. Roughly 10% of proteins in various 
genomes had been predicted to be fully disordered. Presently over 100 IUP's had been identified; none 
are enzymes. Obviously, IUP's were greatly underrepresented in the Protein Data Bank, although there 
were  few  cases  of  an  IUP  bound  to  a  folded  (intrinsically  structured)  protein.  Results:  The  five 
functional categories for intrinsically unstructured proteins and domains were entropic chains (bristles 
to  ensure  spacing,  springs,  flexible  spacers/linkers),  effectors  (inhibitors  and  disassemblers), 
scavengers, assemblers and display sites. These IUPs could serve as potential targets for Structure 
Based Drug Design (SBDD) which stress on the transition from disordered to ordered confirmation 
through drug stimulation. Recently an unstructured domain of a regulatory protein had been found to 
be involved in inhibiting catalytic activity of insulin receptor and targeting this IUP would provide a 
new approach which can be employed in modifying insulin signaling in treatment of diabetes. IUPs 
were also involved diseases and disorders such as cardio vascular diseases, cancers and autoimmune 
disorders. Unstructured proteins had also been shown to be important components of invasion, survival 
and  disguising  strategies  of  pathogens  such  as  Plasmodium  falciparum.  Conclusion:  New  greater 
focuses on proteins that were in some way unstructured normally would promise to provide a greater 
understanding of protein function particularly with respect to protein-protein interactions and hence 
can give new potential targets for future strategies. 
 
Key words: Unstructured proteins, MoRFs, structural transitions, drug targets 
 
INTRODUCTION 
 
  Until recently,  folded three  dimensional structure 
of  protein  is  necessary  for  the  functionality  of  the 
protein was considered to be the classical paradigm of 
structural biology. However, abundance of unfolded or 
coiled proteins in nature, mainly in eukaryotes, has led 
to the discovery of a new group of proteins which are 
not just structurally unfolded but their functionally is 
found  to  be  dependent  on  their  unstructured 
confirmations.  In  many  of  these  proteins  the 
unstructured  confirmation  extends  throughout  the 
protein  and  in  some  it  is  partially  present,  while  in 
others  there  are  long  unstructured  segments  in 
otherwise  ordered  folded  proteins
[1,2].  These 
unstructured proteins play essential roles in cell cycle 
control, transcriptional and translational regulation and 
modulation  of  activity  and/or  assembly  of  other Am. J. Infect. Dis., 5 (2): 126-134, 2009 
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proteins,  signal  transduction  and  even  regulation  of 
nerve cell functions
[3,4]. Numbers of proteins involved 
in protein deposition disorders are now considered to 
belong  to  the  family  of  unstructured  proteins.  For 
example,  Aβ  peptide  and  tau  protein  in  Alzheimer’s 
disease,  PrP  in  Prion’s  disease  and  α-Synuclein  in 
Parkinson’s disease
[3]. This observed intrinsic disorder 
has many important implications on the functional and 
regulatory behavior of IUPs. IUPs show high specificity 
with low affinity, rapid turnover rate and the ability to 
overcome barriers such as steric hindrance that arises 
due to larger surface area and rigid structure of many 
signaling molecules and thermodynamic energy transfer 
during molecular interactions
[5]. As depicted by Protein 
Quartet  Model,  proteins  exist  in  four  different 
confirmations:  ordered  forms,  molten  globules,  pre-
molten  globules  and  random  coils;  each  one  having 
distinct state of activity and regulation
[4]. However, the 
ultimate functioning (activity) of protein is dependent 
on  transitions  between  these  structures.  It  has  been 
confirmed  that  the  unstructured  proteins  undergo 
structural  transitions  between  folded  and  unfolded 
confirmations whenever they interact with their binding 
partner such as modulators, target molecules, specific 
ions or functional regulators
[2]. These transitions form 
the  basis  of  their  functional  regulation  that  could  be 
controlled by introducing their modifiers as drugs. The 
IUPs show interesting features such as modulation in 
their  functional  behavior  through  posttranscriptional 
and  posttranslational  modifications  of  their 
corresponding  mRNAs,  multiple  interactions  which 
have  low  affinity  but  high  specificity  and  most 
importantly,  their  regulation  through  coupled  binding 
and folding transitions
[6]. 
  Here, based on all the above features of IUPs, we 
present the hypothesis that disease associated proteins 
can  be  targeted  for  structural  transition  by  using 
structure based drugs that mimic the binding partner of 
targeted  IUP  and  induce  modulation  in  structure  and 
behavior of targeted IUP. Hence it may be possible to 
alter the folding of target protein to regulate its activity 
and ultimately its function. 
 
Disorders in protein structure: Using data of many of 
the  direct  and  indirect  approaches  such  as  X-ray 
crystallography,  multidimensional  Nuclear  Magnetic 
Resonance  (NMR),  Circular  Dichroism  (CD) 
spectroscopy,  proteolytic  sensitivity  and  heat  stability 
has led to the identification of more than 200 proteins 
and  protein  domains  which  lack  native  folded  3-
Dimentional structure
[7]. In addition to this, the Swiss 
Protein Data Bank has predicted that more than 15,000 
proteins  may  contain  disordered  regions  of  at least 
40  consecutive  amino  acid  residues,  with  more  than 
1050 of them having high scores indicating disorder
[8,9]. 
This  observation  was  accomplished  by  primary 
sequence analysis of proteins, which helped to conclude 
that “a large portion of gene sequences appear to code 
not for folded, globular proteins, but for long patches of 
amino  acids  which  tend  to  be  either  unfolded  in 
solution  or  adopt  non-globular  structures  of 
unstructured conformation”.  
  It  is  known  that  the  sequence  of  amino  acid 
encoded  by  gene  sequence  is  responsible  for  the 
ultimate  stable  3D  structure  of  proteins.  Apart  from 
amino  acid  sequence,  many  things  such  as  charge, 
bulkiness and hydropathy index of amino acids, their 
interactions  with  each  other  etcetera  are  involved  in 
deciding  the  stable  and  functional  three  dimensional 
confirmation  of  any  protein.  Similar  to  the  encoded 
folded structure of any proteins, it can be hypothesized 
that  the  unstructured  or  unfolded  characteristic  of  a 
given protein is also encoded by amino acid sequence 
and hence by underlying genetic sequence
[10]. Certain 
amino  acid  residues  have  been  found  to  be  highly 
"order-promoting"  (namely  cysteine,  tryptophan, 
tyrosine,  isoleucine,  phenylalanine,  valine,  leucine, 
histidine,  threonine  and  asparagine)  while  others  are 
highly  "disorder-promoting"  (namely  aspartic  acid, 
methionine, lysine, arginine, serine, glutamine, proline 
and glutamic acid) (Fig. 1)
[11-14]. These order, disorder 
promoting  amino  acids  can  be  shown  by  Fig.  1,  in 
which  the  relative  amino  acid  compositions  of 
intrinsically  disordered  regions  is  according  to  their 
availability in the DisProt database
[7,15] in comparison 
with a set of structured (or ordered) proteins (Fig. 2)
[12]. 
In  this  case,  these  amino  acid  compositions  were 
compared by means of a profiling approach
[16,17]. 
 
 
  (a)  (b) 
 
Fig. 1:  Some  IUPs  wrap  around  their  partner  upon 
binding.  For  some  IUPs,  the  structure  in  the 
complexed  state  is  known  from  X-ray 
crystallography or NMR. The structures (PDB 
code in parenthesis) shown are: (a): SNAP-25 
bound  to  BoNT/A  (1XTG);  (b):  SARA  SBD 
domain bound to Smad2 MH2 domain (1DEV), 
the  structures  have  been  visualized  by  the 
RasMol
[11] Am. J. Infect. Dis., 5 (2): 126-134, 2009 
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  (a) 
 
 
  (b) 
 
Fig. 2:  Peculiarities  of  the  amino  acid  sequences  of 
intrinsically  disordered  proteins  (a):  Mean  net 
charge  versus  mean  hydropathy  plot  (charge-
hydropathy plot) for the set of 275 folded (blue 
squares) and 91 natively unfolded proteins (red 
circles)
[18]; (b): Amino-acid composition, relative 
to  the  set  of  globular  proteins  Globular-3D,  of 
intrinsically  disordered  regions  10  residues  or 
longer  from  the  DisProt  database.  Dark  gray 
indicates  DisProt  1.0  (152  proteins),  whereas 
light  gray  indicates  DisProt  3.4  (460  proteins). 
Amino  acid  compositions  were  calculated  per 
disordered  regions  and  then  averaged.  The 
arrangement of the amino acids is by peak height 
for the DisProt 3.4 release. Confidence intervals 
were  estimated  using  per-protein  bootstrapping 
with 10,000 iterations
[12] 
 
Unstructured proteins: Structure and functions:  
Structural transitions and functioning: The existence 
of  native  cellular  proteins  can  be  explained  by  the 
Protein Trinity model, which suggests three structural 
confirmations; ordered, molten globule and random coil 
for any given protein in its natural conditions in cell. It 
has  been  suggested  that  the  absolute  function  of  the 
protein  occurs  due  to  its  transitions  between  these 
structures  (Fig.  3)
[4].  Experimental  results  on  the 
confirmational  behavior  of   intrinsically   unstructured 
 
 
Fig. 3:  Extension  of  The  Protein  Trinity  (a):  To  the 
Protein  Quartet  model  of  protein  functioning; 
(b):  In  accordance  with  this  model,  function 
arises  from  four  specific  conformations  of  the 
polypeptide  chain  (ordered  forms,  molten 
globules, pre-molten globules and random coils) 
and transitions between any of the states
[10] 
 
proteins  indicate  that  these  proteins  did  not  possess 
uniform  structural  properties  and  their  states  may  be 
designated  as  intrinsic  coils  and  intrinsic  pre-molten 
globules. Evidences have been reported that the Protein 
Trinity Model can now be extended to Protein Quartet 
model because of existence of four different structural 
confirmations  depicted  as  ordered  forms,  molten 
globules,  pre-molten  globules  and  random  coils.  The 
function of unstructured protein can be fulfilled by their 
rapid fluctuation among alternative states such as coil to 
pre-molten globule transitions, coil to molten globule 
transitions, coil to rigid structure transitions, pre-molten 
globule  to  molten  globule  transitions,  intrinsic  pre-
molten globules to rigid conformation
[5].  
 
Ligand induced folding: In many instances it has been 
shown that ultimate structural transitions of any IUPs 
arise  due  to  its  interaction  with  binding  partners  that 
can be a modulator, regulator or any other protein as 
ligand.  For  example,  partial  folding  in  IUPs  such  as 
thymosin  a1
[19]  and  prothymosin  a  induced  by 
Zn++
[20],  partial  folding  of  human  a-synuclein  in 
presence of several divalent and trivalent metal ions
[21], 
lipid induced transformation of water-soluble form of 
myelin  basic  protein  into  the  molten  globule-like 
conformation
[22],  folding of  RNase P from B. subtilis 
(unfolded in 10 mM sodium cacodilate at neutral pH ) 
into  a  native  a/b  structure  upon  addition  of  various 
small  molecular  anions
[23].  Other  example  of  induced 
folding is shown in Fig. 1 exemplifying the behavior of 
IUPs. Am. J. Infect. Dis., 5 (2): 126-134, 2009 
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Fig. 4: Examples    of    structurally  divergent  MoRFs: 
(a):  An  α-MoRF,  Proteinase  Inhibitor  IA3, 
bound to Proteinase A (1DP5); (b): A β-MoRF, 
viral protein pVIc, bound to Human Adenovirus 
2  Proteinase  (AVP);  (c):  An  ι-MoRF, 
Amphiphysin,  bound  to  α-adaptin  C  (1KY7); 
(d):  A  complex-MoRF,  β-amyloid  precursor 
protein  (βAPP),  bound  to  the  PTB domain  of 
the neuron specific protein X11 (1X11). Partner 
interfaces (gray surface) are also indicated. All 
MoRFs are shown in green. The structures have 
been visualized by the RasMol and PDB code is 
shown in parenthesis 
 
Molecular recognition in IUPs: Though structural data 
shows lack of secondary and tertiary structure, lack of 
understanding  of  atypical  structural  and  functional 
attributes of IUPs would raise many questions against the 
premature  idea  of  complete  lack  of  order.  There  are 
many  well  defined  binding  sites  existing  in  IUPs  that 
allow them to undergo transitions upon interactions with 
their  binding  partners.  A  specialized  subset  of  these 
interacting domains have been recognized as ‘Molecular 
Recognition  Elements’  or  “Molecular  Recognition 
Features”  which  are  protein  regions  that  specifically 
participate in protein-protein interactions. These MoRFs 
have the ability to undergo significant induced folding 
steps  or  disorder-to-order  transition
[1,3,18]  together  with 
the change in the structure of their binding partners. Such 
molecular recognition mechanism, which is coupled to 
the  folding  process,  has  been  noted  to  confer 
exceptionally high specificity and low affinity; binding 
diversity and binding commonality to their IUPs
[10]. 
  According to current understanding depending on 
their  structures  in  the  bound  state  MoRFs  can  be 
divided into three subtypes: a-MoRFs form a-helices, 
β-MoRFs form β-strands and ι-MoRFs form structures 
without a regular pattern of backbone hydrogen bonds 
(Fig.  4),  along  with  their  observed  mixtures
[24,25]. 
Although  only  a  few  MoRFs  have  been  studied 
experimentally, it has been suggested that all MoRFs 
are  intrinsically  disordered  in  the  absence  of  their 
binding  partners  in  line  with  observations  of 
Gunasekaran  et  al.
[26]  who  have  demonstrated  that 
intrinsic disorder in the unbound state is reflected in the 
structures  of  the  bound  state  through  relatively  large 
surface  and  interface  areas.  With  the  discovery  of 
MoRFs  it  can  be  supposed  that  IUPs  function  by 
molecular  recognition  which  may  be  transient  or 
permanent binding to a binding partner. In general, for 
IUPs to assume a folded confirmation, prior to binding 
to modulators or targets, is difficult as a consequence of 
many  topological/structural  constraints.  Binding  of 
target molecules and/or modulators to the IUP increases 
its flexibility in terms of topological stress to reach to 
the final functional state aided by MoRFs. Numbers of 
IUPs have been found to bind to many different types 
of partners and vice versa a molecule of modulator can 
bind with many different types of IUPs. Interestingly, 
both these conditions result in different confirmations 
of IUPs with different combination of an IUP and its 
binding partner. This flexibility and low affinity with 
high  specificity  of  IUPs  for  their  binding  partners, 
which actually is an attribute of MoRFs, increases the 
probability of multiple interactions that allow control of 
many processes that have common checkpoints. 
  The  structural  flexibility  that  occurs  due  to 
molecular recognition has actually been demonstrated 
for  the  C-terminal  domain  of  DNA  dependent  RNA 
polymerase II (RNAP II) bound to either RNA guanylyl 
transferase Cgt1 or peptidyl-proline isomerase Pin1
[27] 
and the HIF-1a-interaction domain bound to either the 
TAZ1  domain  of  cAMP  response  element  binding 
protein  (CREB)-binding  protein  (CBP)
[28]  or  the 
asparagine  hydroxylase  FIH
[29].  Thus,  the  function  of 
IUPs  arises  either  from  their  transitions  between 
alternative  states  as  described  previously  or  through 
molecular recognition and induced folding. 
 
Unstructured proteins in diseases: The D
2 concept: 
Proteins  are  essential  for  functioning  of  any  cell 
because of their involvement in each and every step of 
cellular activity such as metabolism and its regulation, 
signaling, transport, defense and many more. Hence it 
is  not  surprising  that  number  of  diseased  conditions 
arise due to failure of a specific peptide or protein to 
adopt its proper structure. Such diseases are associated 
with  protein  misfolding  which  include  protein 
aggregation  (and/or  fibril  formation),  loss  of  normal 
function  and  gain  of  toxic  function.  Some  proteins 
assume pathologic state due to some of the endogenous 
factors  such  as  chaperones,  intracellular  or  extra Am. J. Infect. Dis., 5 (2): 126-134, 2009 
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cellular  matrices, other proteins and small  molecules, 
which can alter the confirmation of a pathogenic protein 
and thereby increase its chances of getting misfolded. 
Increase  in  rate  of  pathogenic  misfolded  protein 
accumulation  may  increase  because  of  ageing, 
mutation, or other induced conditions leading to disease 
progression. 
  Some of the proteins shown to be reason for human 
diseases such as cancer, Parkinson's disease and other 
synucleinopathies, Alzheimer's, prion diseases, diabetes 
and  cardiovascular  disease  are  either  completely 
disordered or contain long disordered regions. In fact, 
the analysis on Swiss-Prot suggests strong association 
of  intrinsic  disorder  and  diseases  such  as  malaria, 
trypanosomiasis,  Human  Immunodeficiency  Virus 
(HIV)  and  acquired  immunodeficiency  syndrome 
(AIDS),  deafness,  obesity,  cardiovascular  disease, 
diabetes mellitus, albinism and prion (Fig. 5)
[30]. Thus, 
intrinsic disorder is very common in disease-associated 
proteins that have given rise to a disorder in disordered 
proteins  concept,  which  is  now  calling  the  "D2 
concept"
[6]. 
 
Drug discovery based on protein structure: Proteins 
are highly  favored targets  for future drug discoveries 
for  protein  associated  diseases  since  long.  However, 
literature  surveys  have  failed  to  give  example  of 
currently  used structure based drugs targeted towards 
proteins. There has been only a little success in finding 
drugs  which  act  by  blocking  protein-protein 
interaction
[10,31]. 
 
 
(a)  (b)  (c)  (d)  (e) 
 
Fig. 5:  Disease    associated    unstructured      proteins: 
(a): α-Synuclein; (b): Major prion protein; (c): 
p53 tumor antigen; (d): Tat protein from HIV; 
(e) Apical membrane antigen 1 (AMA1) of the 
malarial    parasite    Plasmodium      falciparum 
upper  raw  shows  the  structures  of  proteins 
according  to  their  chains  and  the  lower  raw 
shows  the  structures  according  to  the 
confirmation
[30]  
  Many  studies  have  revealed  several  important 
features  of  protein-protein,  protein-modulator  and 
protein-binding partner interactions which can serve to 
determine  drug  targets  and  potential  ligands.  Further, 
all these interactions can be extended for those which 
comprise  one  of  the  partners  having  an  unstructured 
region  else,  they  themselves  are  wholly  unstructured 
protein.  Moreover  there  are  many  features  of 
unstructured  proteins  that  make  them  suitable  drug 
targets. Firstly, their structural transitions which make 
them prone to induced folding which in turn regulate 
their  functionality.  Secondly,  MoRFs  exhibit  some 
special features that make them stabilize the transient 
forms.  For  example,  binding  with  partner  promotes 
organization of disordered region into a helix or other 
structure  with  hydrophobic  side  chains  that  project 
away  from  the  backbone  and  into  the  cleft
[24].  With 
respect  to  this  the  p53/Mdm2  interaction  can  be 
considered  here,  in  which  the  p53  binding  site  is 
predicted  to  be  an  α-MoRF  and  this  binding  site 
contains  hydrophobic  side  chains  that  project  deeply 
into  the  cleft  located  on  the  surface  of  the  Mdm2 
partner upon binding. This in turn provides utilization 
of disorder to order transition with spending of energy 
which  results  in  decrease  of  entropy.  The  interaction 
between  p53/Mdm2  can  be  easily  blocked  and/or 
targeted by small structure based drugs. Some of the 
examples  discussed  in  recent  reviews  depend  on  one 
structured partner and one disorder partner that undergo 
helix formation upon binding MoRF and its partner
[31]. 
Given  this,  IUPs  involved  in  some  very  important 
diseases can be targeted for drug discoveries. 
  The  preS1  surface  antigen  of  Hepatitis  B  Virus 
(HBV)  is  known  to  play  important  role  in  the  initial 
attachment  of  HBV  to  hepatocytes  and  is  natively 
unstructured  protein.  The  N-terminal  50  residues  of 
preS1  that  are  populated  with  multiple  pre-structured 
motifs  (MoRFs),  contribute  critically  to  hepatocyte 
binding.  There  are  some  overlapping  pre-structured 
motifs  identified  in  preS1  that  show  folding  upon 
binding  to  monoclonal  antibodies  and  should  help  to 
determine regions that can be used to design structure-
based inhibitors against HBV attachment to hepatocytes 
once an HBV receptor is identified
[32].  
  a-Synuclein is a small (14 kDa) highly conserved 
protein  and  is  intrinsically  unstructured,  i.e.,  natively 
unfolded
[33].  Upon  interaction  with  intracellular 
molecules  such  as  phospholipids,  α-Synuclein 
undergoes confirmational change from an unstructured 
monomer in solution to organized structure related to β 
conformation
[30].  This  ultimate  organized  structure 
forms  the  basis  of  aggregation  and  fibrillation,  along 
with an intermediate that is found in Lewy bodies
[34]. Am. J. Infect. Dis., 5 (2): 126-134, 2009 
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However,  the  existence  of  such  an  intermediate 
between  folded  and  unfolded  confirmations,  on  the 
pathway to fibrils, lead to population of the intermediate 
that  shifts  the  equilibrium  position  from  the  natively 
unfolded state to a partially folded intermediate through 
any intracellular factors increasing the likelihood of α-
synuclein  fibril  formation  and  development  of 
Parkinson’s disease. Such factors could include relatively 
nonpolar molecules that would preferentially bind to the 
intermediate.  Similarly,  the  tau  protein  exists  as 
unstructured  protein  with  little  α-helical  or  β-sheet 
structure
[35] that is modulated by heparin binding which 
in  turn  is  an  IUP
[30].  However,  the  association  of  tau 
protein with Alzheimer’s disease shows the aggregation 
consisting  of  PHF  (parallel  helix  filaments)  in  β 
amyloid  fibrils  mediating  intracellular  inclusions  and 
neurodegeneration suggesting transition of an unfolded 
structure into an ordered state
[36]. In fact the abnormal 
phosphorylation  observered  in  tau  protein  aggregates 
are  at  the  unstructured  sites  of  the  protein
[37].  This 
finding  can  be  linked  to  an  assumption  that 
hyperphosphorylation  might  be  involved  in  the 
observed  structural  transition  of  tau  protein  causing 
abnormal  microtubule  association  and  hence  bringing 
neurological disorder. In support of such a connection, 
it  can  be  said  that  those  molecules  that  can 
preferentially bind to α-synuclein or tau may decrease 
or prevent the rate of fibril formation and even prevent 
accumulation  of  partially  folded  intermediate  or 
aggregates.  
  The  central  event  in  the  pathogenesis  of  prion 
diseases is a major confirmational change in the prion 
protein  (PrP)  normal  cellular  form  containing  a 
preponderance of helical secondary structure to a plaque 
forming confirmer containing a greater proportion of β-
sheet. Structure determination of fragments  of  the prion 
protein  revealed  that  around  100  residues  at  the  C 
terminus are folded into a largely helical domain with 
completely unfolded N-terminal
[38]. Partial folding of a 
local region is shown to be assisted by presence Cu(II) 
ions
[39] and may give a clue to the overall physiological 
function  of  the  prion  protein,  which  at  present  is 
unknown. If this protein functions as a copper storage or 
transport  protein,  the  extreme  flexibility  of  the  N 
terminus is probably of functional significance that can 
be aimed for regulating transition of prion protein.  
  The presence of disorder has been directly observed 
in many cancer-associated proteins, a few examples of 
which include p53
[40], p57kip2
[41], Bcl-XL and Bcl-2
[42], 
c-Fos
[43], proto-oncogene securing
[44] and a breast cancer 
associated  protein  BRCA1
[45]  along  with  recently 
discovered E6 and E7 oncoproteins from the high-risk 
types of Human Papillomaviruses (HPVs)
[46]. Amongst 
these  Bcl-2  has  been  characterized  as  drug  targets. 
Additionally,  small-molecule  antagonists  have  recently 
been described for several new targets, including Rac1-
Tiam1, beta-catenin-T cell factor (Tcf) and Sur-2-ESX 
that are involved in cancer progression
[31].  
  Other  unstructured  proteins that are shown to be 
associated  with  diseases  and  are  potential  targets  for 
structure  based  drug  design  include:  (A)  Insulin-like 
Growth  Factor  Binding  Proteins  (IGFBPs)  that  are 
carriers and regulators of the insulin like growth factors 
having C-terminal domain with three hightly disordered 
loops
[47]. (B) Two intracellular domains of connexin43 
(Cx43),  cytoplasmic  loop  95-144  and  C-terminal 
domain  (amino  acids  254-382)  possessing  short 
transient  R-helices  with  numerous  binding  partners 
identified;  these  include  tubulin,  v-Src,  c-Src,  ZO-1, 
Casein  Kinase  1  (CK1),  Mitogen-Activated  Protein 
Kinase  (MAPK),  cGMP-dependent  protein  kinase, 
cAMP-dependent  protein  kinase  and  protein  kinase 
C
[48]. (C) Numerous proteins associate with obesity and 
CVD  have  been  identified  to  have  long  regions  of 
intrinsic  disorder  containing  R-helices  and  α-MoRFs, 
predicted  in  101  proteins  from  CVD  data  set
[49].  (D) 
Apical Membrane Antigen 1 (AMA1) of the malarial 
parasite P. falciparum is a merozoite antigen, has well-
defined, disulfide-stabilized core region separated by a 
disordered loop and both the N-and C-terminal regions 
of  the  molecule  are  unstructured
[50].  (E)  Tat 
(transactivator of transcription) is a small RNA-binding 
protein that helps in HIV-1 replication is an IUP and 
shows induced folding when it interacts with its binding 
partner-cyclin T1 along with its ability to interact with 
wide variety of proteins
[51].  
 
CONCLUSION 
 
  Altogether,  it  can  be  said  that  the  discovery  of 
small  drug  molecules  that  can  target  protein-protein 
interaction  is  difficult  even  for  structured  proteins. 
Consequently there are some important prospects that 
should  be  considered  while  targeting  interactions 
involving  unstructured proteins  with  molecular drugs. 
For  example,  affinity  of  molecule  to  the  protein 
(frequently  subnanomolar)  that  can  successfully 
compete  for  binding  to  its  site
[52],  the  biology  of  the 
system  and  understanding  molecular  recognition  of 
protein surfaces. 
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